On 5 November 2026, IFPMA delivered a statement on technology transfer at WIPO’s 38th Standing Committee on Patents. IFPMA notes the study in document SCP/38/9 on collaboration between industry and academia. We welcome the study’s recognition that robust intellectual property frameworks, capable partners, and appropriate financing help turn research into practical applications. Furthermore, we welcome...
Read moreOn 4 November 2026, IFPMA delivered a statement on patents and health at WIPO’s 38th Standing Committee on Patents. A robust, stable, and predictable intellectual property system supports research and development, investment, and voluntary partnerships needed to translate scientific discoveries into innovative medicines and vaccines. As users of the patent system, including the Patent Cooperation...
Read moreOn 26 August, IFPMA delivered a statement on the special update on the ongoing Ebola virus disease outbreak caused by Bundibugyo Virus at the 76th session off the WHO Regional Committee for Africa in Addis Ababa. Marking the 100th day after the Bundibugyo outbreak was declared, the global pharmaceutical industry underscores its commitment and track...
Read more